Register

Registration

Note : After Answered of Questionnaires / Survey Please Close it.
.

Fredun Pharmaceuticals Ltd . Small Cap

BSE: 539730 | NSE:
Pharmaceuticals
Live
20/04/2021 4:00:00 PM
422.00 -21.95   (-4.94%)
BSE: price shown with 5 mins delayed.
Prev. Close 443.95
Open Price 449.95
Volume Traded 1818.00

Fundamentals

Mar'11 Mar'12 Mar'13 Mar'14 Mar'15 Mar'16 Mar'17 Mar'18 Mar'19 Mar'20
Ajusted EPS(Rs.)
Net Sales (Rs. Cr.)
Adjusted Net Profit
Book Value/ Share(Rs.)
Cash Flow
Debt to Cash Flow from Operations
RONW
ROCE %
Net Operating Profit Margin %
Net Profit Margin %
Debt / Equity
Dividend Yield %
Mar'11 Mar'12 Mar'13 Mar'14 Mar'15 Mar'16 Mar'17 Mar'18 Mar'19 Mar'20
Ajusted EPS(Rs.) 0 0 0.3 1.02 1.08 4.28 5.31 5.11 11.18 4.77
Net Sales (Rs. Cr.) 7.97 11.68 15.08 21.28 25.36 42.32 56.7 59.55 97.02 112.77
Adjusted Net Profit 0.00 -0.18 0.06 0.24 0.26 1.11 1.39 1.75 4.46 1.90
Book Value/ Share(Rs.) 11.24 10.13 10.06 10.96 11.94 15.62 20.05 64.71 97.73 103.57
Cash Flow 0.11 0.00 0.23 -0.15 0.19 0.79 -0.64 0.71 0.02
Debt to Cash Flow from Operations 17.83 0.00 3.88 -10.43 5.08 4.67 4.63 0.57 -2.92
RONW 0.00 0.00 1.68 9.64 9.58 32.11 29.75 13.00 14.58 4.73
ROCE % 9.57 8.92 16.12 13.97 13.92 24.13 17.88 14.95 19.63 10.16
Net Operating Profit Margin % 4.11 1.46 5.64 4.52 4.22 6.24 5.93 6.60 7.72 3.88
Net Profit Margin % 0.00 -1.63 0.38 1.11 1.03 2.53 2.52 2.94 4.60 1.68
Debt / Equity 1.32 1.61 1.91 2.21 2.73 3.50 3.02 0.96 0.48 0.67
Dividend Yield % 0.00 0.00 0.00 0.00 0.00 4.80 0.16 0.21 2.74 0.15

Year on Year Growth Rate (%)

Ajusted EPS Sales Adjusted Net Profit

Latest Financials

Standalone Consolidated
TTM EPS (Rs) 7.89
TTM Sales (Rs. Cr.) 114.85
BVPS (Rs.) 105.07
Reserves (Rs. Cr.) 37.93
P/BV 4.14
PE 56.27
From the Market
52 Week High / Low (Rs) 597/146.6
All Time High / Low (Rs) 359/12.5
Volume Traded 1818
Market Cap (Rs. Cr.) 177.12
Equity (Rs. Cr.) 3.989634
Face Value (Rs) 10
Industry PE 0

Quarterly Results

Mar'2020 Jun'2020 Sep'2020 Dec'2020
Net Sales (Cr) 24.42 13.26 32.07 45.10
Adjusted EPS (Rs) -0.53 0.10 4.99 3.36
Net Profit Margin % -0.86 0.30 6.21 2.97
Mar'2020 Jun'2020 Sep'2020 Dec'2020
Net Sales (Cr)
Adjusted EPS (Rs)
Net Profit Margin %

Quarterly Growth Rate (%)

Ajusted EPS Sales Net Profit Margin

Peers Data

Name Current Price(Rs) Market Cap. (Rs. cr.) Net Profit(Rs. cr.) Sales Growth(%)

Technical

Sector

23387.09 280.75   (1.22%)

Index

47705.80 -243.62   (-0.51%)
9 Days Avg
Span A Span B 52 Week TenKan-Sen Kijun-Sen ChiKou-Sen
9 Days Avg

Score

Kindly subscribe to get access

Research Analytical

Kindly subscribe to get access

News

About Company

Incorported in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94. It was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietory firm, for the manufacture and export of pharmaceutical formulations. The exports were mainly to Afghanistan and west Africa. Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. FPL was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, dry-syrups and ointments. It then set up a formulation unit at Palghar (Thane district), Maharashtra, which commenced commercial production in Aug.'94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters, including Merind.In Apr.'96, the company came out with a public issue to register its products in the overseas market for exports; to part-finance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of company's turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal, Tanzaniya, Uganda & Sri Lanka.